Evidence map›Paper›PMID 28963502›Full record

ArticleScientific reports2017

Epithelial Chloride Transport by CFTR Requires TMEM16A.

Roberta Benedetto, Jiraporn Ousingsawat, Podchanart Wanitchakool, Yong Zhang, Michael J Holtzman, Margarida Amaral, Jason R Rock, Rainer Schreiber, Karl Kunzelmann

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 119 citations in OpenAlex.

  1. Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Trial
  2. Review
  3. Review
  4. [Transmembrane protein 16A--a new target for the treatment of airway inflammatory diseases].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Dietary NaCellular and molecular life sciences : CMLS · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Roberta BenedettoPhysiological institute, University of Regensburg, University street 31, D-93053, Regensburg, Germany.
Jiraporn OusingsawatPhysiological institute, University of Regensburg, University street 31, D-93053, Regensburg, Germany.
Podchanart WanitchakoolPhysiological institute, University of Regensburg, University street 31, D-93053, Regensburg, Germany.
Yong ZhangDepartment of Medicine and Department of Cell Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
Michael J HoltzmanDepartment of Medicine and Department of Cell Biology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0001-8750-3716
Margarida AmaralUniversity of Lisboa, Faculty of Sciences, BioISI - Biosystems & Integrative Sciences Institute, Campo Grande, C8, 1749-016, Lisboa, Portugal.ORCID 0000-0002-0828-8630
Jason R RockDepartment of Anatomy, University of California, San Francisco, USA.
Rainer SchreiberPhysiological institute, University of Regensburg, University street 31, D-93053, Regensburg, Germany.
Karl KunzelmannPhysiological institute, University of Regensburg, University street 31, D-93053, Regensburg, Germany. karl.kunzelmann@ur.de.
University of Regensburg · DEWashington University in St. Louis · USUniversity of California, San Francisco · USUniversity of Lisbon · PT

Funding

The role of CARDS toxin in genesis and exacerbation of allergic inflammationU19AI070412 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HART, PETER JOHN · 2006 to 2015
$19.7M
Tissue and Cell Processing CoreU19AI070489 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2006 to 2016
$17.9M
Preclinical Development of an Anti-Mucus DrugUH3HL123429 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2016 to 2018
$4.7M
Preclinical Development of an Anti-Mucus DrugUH2HL123429 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2015
$3.0M
IL-33 AND EXCESS MUCUS PRODUCTIONR01HL121791 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2017
$1.9M
NHLBI NIH HHS R01 HL121791NHLBI NIH HHS UH2 HL123429NHLBI NIH HHS UH3 HL123429NIAID NIH HHS U19 AI070412NIAID NIH HHS U19 AI070489
6 · The paper itself

Abstract

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is the secretory chloride/bicarbonate channel in airways and intestine that is activated through ATP binding and phosphorylation by protein kinase A, but fails to operate in cystic fibrosis (CF). TMEM16A (also known as anoctamin 1, ANO1) is thought to function as the Ca

Indexed as

AnimalsAnoctamin-1Biological TransportCell LineChloridesCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsHumansMice, KnockoutNeoplasm ProteinsANO1 protein, humanANO1 protein, mouseAnoctamin-1ChloridesCystic Fibrosis Transmembrane Conductance RegulatorNeoplasm Proteins

Identifiers

PMID28963502
PMCPMC5622110
OpenAlexW2758223210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.